An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
Part of paid clinical trials in Chandler, Arizona.
- Sponsor
- Dompé Farmaceutici S.p.A
- Study ID
- NCT07503886
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Dry Eye Disease (DED)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- DFL24498 — DRUGOne drop of reconstituted DFL24498 will be instilled topically in each eyes 4 times a day (QID) for 12 weeks.
- Vehicle — OTHEROne drop of reconstituted Vehicle will be instilled topically in each eyes QID for 12 weeks.
Study Details
This is a Phase 2, randomized, multicenter, double masked, vehicle controlled, parallel group study to evaluate the efficacy and safety of DFL24498 topical ophthalmic solution versus vehicle in participants with dry eye disease. Approximately 417 participants aged 18 years or older who meet all eligibility criteria will be enrolled at study sites in the US. The study duration will be up to 16 weeks and will consist of three periods.
Key Dates
- First listed
- Mar 31, 2026
- Start date
- May 12, 2026
- Status verified
- Jun 2026
- Primary completion
- Jan 24, 2027
- Completion
- Feb 7, 2027
Study Design
- Enrollment
- 417 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: DFL24498Participants will receive DFL24498 opthalmic solution administered topically in both eyes.
- Placebo Comparator: VehicleParticipants will receive vehicle opthalmic solution administered topically in both eyes.
Primary Outcome Measure
Change from baseline in corneal fluorescein staining (CFS) assessed by National Eye Institute (NEI) scale (0 to 15) in the Study Eye [ Time Frame: Baseline to Week 12 ]
Central Contacts
- Dompé farmaceutici S.p.A. Via Santa Lucia, 6, 20122 Milan (MI)+39 02 583 831
Locations (24)
Find similar trials in Chandler, AZ
Related Studies
- The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier FunctionPHASE4 · Recruiting · Southern California College of Optometry at Marshall B. Ketchum University · Fullerton, California
- SYSTANE® PRO vs. MIEBO™ in Dry Eye DiseasePHASE4 · Recruiting · Indiana University · Newport Beach, California
- Moderate-to-Severe Dry Eye Disease Relief Using AcoltremonEnrolling By Invitation · Colvard Kandavel Eye Center · Encino, California
- A Clinical Study Evaluating Licaminlimab for Dry Eye DiseasePHASE2/PHASE3 · Recruiting · Oculis · Aliso Viejo, California